MedTrace Logo

The Role of Adjuvant Albendazole After Pulmonary Hydatid Cyst Resection

NCT06483880 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-02-17

No results posted yet for this study

Summary

The aim of this study is to study the role of adjuvant Albendazole after pulmonary hydatid cyst resection versus placebo in reducing recurrence with a short- term follow-up of six months.

Conditions

  • Pulmonary Hydatid Cyst

Interventions

DRUG

Albendazole

Patients will receive albendazole therapy at the recommended dosage.

DRUG

Placebo

Patients will receive the placebo, which will be starch tablets in the same dosage of albendazole.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2025-06-01
Completion
2025-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06483880 on ClinicalTrials.gov